Holen Sie sich die Stockscreener-App
28.17
2.32%
0.64
Schlusskurs vom Vortag:
$27.53
Offen:
$27.58
24-Stunden-Volumen:
2.05M
Relative Volume:
1.53
Marktkapitalisierung:
$5.20B
Einnahmen:
$797.73M
Nettoeinkommen (Verlust:
$-325.77M
KGV:
-15.89
EPS:
-1.7725
Netto-Cashflow:
$-332.79M
1W Leistung:
-7.00%
1M Leistung:
-14.27%
6M Leistung:
-0.56%
1J Leistung:
-29.13%
1-Tages-Spanne:
$27.40
$28.25
1-Wochen-Bereich:
$27.40
$30.55
52-Wochen-Spanne:
$27.34
$44.90
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Firmenname
Legend Biotech Corp Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie LEGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
28.17 | 5.08B | 797.73M | -325.77M | -332.79M | -1.7725 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-10-08 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-06-17 | Eingeleitet | Truist | Buy |
| 2024-05-24 | Bestätigt | H.C. Wainwright | Buy |
| 2024-05-23 | Eingeleitet | Deutsche Bank | Buy |
| 2024-04-17 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Eingeleitet | Raymond James | Outperform |
| 2023-12-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-11-06 | Eingeleitet | Goldman | Buy |
| 2023-05-25 | Eingeleitet | William Blair | Mkt Perform |
| 2023-05-22 | Eingeleitet | Daiwa Securities | Buy |
| 2023-03-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-03-24 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-11-02 | Eingeleitet | Evercore ISI | Outperform |
| 2022-11-01 | Eingeleitet | Cowen | Outperform |
| 2022-10-31 | Eingeleitet | Guggenheim | Neutral |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-03-15 | Eingeleitet | Barclays | Overweight |
| 2022-01-31 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-01 | Eingeleitet | Jefferies | Buy |
| 2020-06-30 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Legend Biotech Corp Adr Aktie (LEGN) Neueste Nachrichten
Artisan Partners Limited Partnership Buys 990,500 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034 - GlobeNewswire Inc.
FY2025 EPS Estimates for Legend Biotech Reduced by Analyst - Defense World
Take off with Legend Biotech Corp ADR (LEGN): Get ready for trading - Setenews
Company News for Nov 13, 2025 - sharewise.com
Earnings call transcript: Legend Biotech’s Q3 2025 results miss forecasts By Investing.com - Investing.com Philippines
Earnings call transcript: Legend Biotech’s Q3 2025 results miss forecasts - Investing.com
A History of Outperforming Analyst Forecasts and Beating the Odds: SharkNinja Inc (SN) - setenews.com
The growth track for Legend Biotech Corp ADR (LEGN) has changed recently - Setenews
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A new trading data show Legence Corp (LGN) is showing positive returns. - Setenews
iA Global Asset Management Inc. Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Reduces Holdings in Essential Properties Realty Trust, Inc. $EPRT - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 11,157 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Clean Harbors (NYSE:CLH) Shares Gap Down on Disappointing Earnings - Defense World
What Recent Developments Mean for Legend Biotech’s Outlook and Valuation - Yahoo Finance
OVERSEA CHINESE BANKING Corp Ltd Invests $723,000 in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Allianz Asset Management GmbH Takes $458,000 Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Nordea Investment Management AB - MarketBeat
TD Asset Management Inc Has $3.67 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
CorMedix (CRMD) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth - Investing.com India
Ameritas Advisory Services LLC Makes New $32,000 Investment in Arbor Realty Trust $ABR - Defense World
Free cash flow per share of Legend Biotech Corp. Sponsored ADR – MUN:9LB - TradingView
Ameritas Advisory Services LLC Acquires Shares of 501 JPMorgan Diversified Return International Equity ETF $JPIN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $69.25 Average PT from Analysts - Defense World
Vontobel Holding Ltd. Has $368,000 Holdings in Duolingo, Inc. $DUOL - Defense World
Vontobel Holding Ltd. Sells 1,634 Shares of Wynn Resorts, Limited $WYNN - Defense World
Avery Dennison (NYSE:AVY) Receives “Hold (C-)” Rating from Weiss Ratings - Defense World
Pagaya Technologies (NASDAQ:PGY) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Vontobel Holding Ltd. Makes New Investment in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Vontobel Holding Ltd. Sells 15,564 Shares of SS&C Technologies Holdings, Inc. $SSNC - Defense World
Vontobel Holding Ltd. Cuts Stock Position in Waters Corporation $WAT - Defense World
Vontobel Holding Ltd. Acquires 1,390 Shares of Corsair Gaming, Inc. $CRSR - Defense World
Vontobel Holding Ltd. Sells 10,000 Shares of Zeta Global Holdings Corp. $ZETA - Defense World
Bennett Associates Wealth Management Has $523,000 Holdings in JPMorgan Chase & Co. $JPM - Defense World
Analysts Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $69.25 - Defense World
US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy By Reuters - Investing.com
JPMorgan Chase & Co. Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $76.00 - Defense World
Mirae Asset Global Investments Co. Ltd. Has $530,000 Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
US FDA adds boxed warning to J&J, Legend Biotech’s cancer therapy By Reuters - Investing.com
Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World
GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Matthews International Capital Management LLC Has $45.89 Million Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Finanzdaten der Legend Biotech Corp Adr-Aktie (LEGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):